Ambu surpasses Q1 expectations and hits significant milestone

Medtech firm Ambu surpasses analyst expectations for Q1 with revenue exceeding DKK 1bn. For the first time, the firm hits the billion-kroner mark already in Q1.
Photo: PR / Ambu
Photo: PR / Ambu

Ambu is powering ahead in its Q1. For the first time, the pharmaceutical firm's revenue has reached the DKK 1bn (USD 163.3m) mark early in the year.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
  • Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
    Must contain at least 2 characters
    Must contain at least 2 characters

    Get full access for you and your coworkers

    Start a free company trial today

    Share article

    Sign up for our newsletter

    Stay ahead of development by receiving our newsletter on the latest sector knowledge.

    Newsletter terms

    Front page now

    Further reading